Laurus Labs Limited
LAURUSLABS
Rank in Stocks
#1791
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Share Price
$22.18
Market Cap
$11.98B
Change (1 day)
-2.87%
Change (1 year)
111.30%
Country
IN
Trade Laurus Labs Limited (LAURUSLABS)
Category
Healthcare
Stock price history for Laurus Labs Limited (LAURUSLABS)
Highest end of day price: $22.40 on 2026-10-01
Lowest end of day price: $1.40 on 2016-12-01
Lowest end of day price: $1.40 on 2016-12-01
Stock price history of Laurus Labs Limited from 2016 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 27.34% |
| 2025 | 70.39% |
| 2024 | 41.93% |
| 2023 | -0.76% |
| 2022 | -29.22% |
| 2021 | 48.80% |
| 2020 | 363.18% |
| 2019 | -8.79% |
| 2018 | -34.42% |
| 2017 | 17.43% |
| 2016 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 21.02% |
DE
|
|
| $41.46 | 47.41% |
JP
|
|
| $212.49 | 23.19% |
CH
|
|
| $19.19 | -0.09% |
IN
|
